Nuclear medicine's dominant force, SPECT, faces growing pressure from enforcement agencies focused on the field, known as PET agents.

In the dynamic world of healthcare, India continues to make significant strides in integrating technology to improve patient care. Here's a snapshot of some recent developments that are shaping the landscape:

IIITH Hosts ABDM 2.0 Consultation

The International Institute of Information Technology, Hyderabad (IIITH) played host to the ABDM 2.0 Southern Region Consultation Meeting, organised by the National Health Authority. The meeting aimed to discuss and strategise the implementation of the National Digital Health Mission's second phase, focusing on digital health infrastructure and services in the southern region.

Novo Nordisk Partners with Apollo Clinics

Novo Nordisk, a global leader in diabetes care, has teamed up with Apollo Clinics to launch an Obesity Clinic Program in India. This collaboration is set to address the growing concern of obesity and related health issues in the country, providing comprehensive care to those in need.

Leadership at P. D. Hinduja Hospital

At P. D. Hinduja Hospital & Medical Research Centre, Dr. Aparna Joshi has taken the helm as the founder or director of the newly opened senior centre. The centre aims to provide dedicated care and services for the elderly, while the hospital's recently launched Geriatric Clinic focuses on comprehensive healthcare for the geriatric population.

AI in IVF Labs

Nova IVF Fertility has embraced technology in a significant way, implementing Artificial Intelligence in their IVF labs for embryo selection. This cutting-edge technology is expected to enhance the accuracy and efficiency of the embryo selection process, potentially increasing the chances of successful pregnancies.

Mahajan Imaging & Labs Partners with Fortis La Femme

Mahajan Imaging & Labs has joined forces with Fortis La Femme to strengthen women and child healthcare services in India. The partnership is set to provide comprehensive healthcare solutions, encompassing imaging diagnostics, fertility treatments, and women's health services.

Positive Results from Zydus Therapeutics' Trial

Zydus Therapeutics has reported positive topline results from the EPICS-III Phase 2(b)/3 Trial. The trial focused on the company's investigational therapy for epilepsy, marking a significant step forward in the development of potential treatments for this neurological disorder.

These developments underscore India's commitment to leveraging technology to improve healthcare outcomes and provide better, more accessible care to its citizens. As these initiatives continue to unfold, the healthcare landscape in India is poised for exciting transformations.

Nuclear medicine's dominant force, SPECT, faces growing pressure from enforcement agencies focused on the field, known as PET agents.